Inability to detect an inhibitor of thyroxine-serum protein binding in sera from patients with nonthyroid illness
- 31 May 1991
- journal article
- Published by Elsevier in Metabolism
- Vol. 40 (5) , 491-502
- https://doi.org/10.1016/0026-0495(91)90230-t
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- IS OLEIC ACID THE THYROXINE BINDING INHIBITOR IN THE SERUM OF ILL PATIENTS?Clinical Endocrinology, 1989
- Sera containing elevated nonesterified fatty acids from patients with angiographically documented coronary atherosclerosis cause marked lipid accumulation in cultured human arterial smooth muscle-derived cellsAtherosclerosis, 1988
- Thyroid Hormone Binding Inhibitor (THBI) Mainly Associated with Serum Oleic Acid ConcentrationHormone and Metabolic Research, 1985
- New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.Journal of Clinical Investigation, 1984
- Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.Journal of Clinical Investigation, 1983
- Studies on human thyroxine-binding globulin (TBG). IX. Some physical, chemical, and biological properties of radioiodinated TBG and partially desialylated TBG.Journal of Clinical Investigation, 1975
- Measurement of Circulating Desialylated Glycoproteins and Correlation with Hepatocellular DamageJournal of Clinical Investigation, 1974
- Studies on Human Thyroxine-Binding GlobulinJournal of Clinical Investigation, 1972
- SERUM-THYROXINE AND THYROXINE-BINDING GLOBULIN IN SERIOUSLY ILL PATIENTSThe Lancet, 1971
- BIOCHEMICAL APPLICATIONS OF A NEWLY DISCOVERED PROPERTY OF THYROXINEAnnals of the New York Academy of Sciences, 1960